Evidence map›Paper›PMID 23741498›Full record

ArticlePloS one2013

Pulsed electromagnetic fields increased the anti-inflammatory effect of A₂A and A₃ adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts.

Fabrizio Vincenzi, Martina Targa, Carmen Corciulo, Stefania Gessi, Stefania Merighi, Stefania Setti, Ruggero Cadossi, Mary B Goldring, Pier Andrea Borea, Katia Varani

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05922618 (PEMFS in Patients With CRPS-I of the Foot and Ankle), which is not on this map. Cited by 69 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 2 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05922618 nacompletednot on this mapstarted 2023, after this paper: background citation

PEMFS in Patients With CRPS-I of the Foot and Ankle: a Randomized Controlled Trial

TypeinterventionalSponsorAzienda Ospedaliero-Universitaria Consorziale Policlinico di BariRan2023 to 2025Enrolled28ConditionsPain, Joint, Complex Regional Pain Syndromes, Ankle Disease, Foot DiseasesArmsI-One
3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. No superior treatment for primary osteochondral defects of the talus.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2018
    Pooled it
  3. Trial
  4. Effect of Dermal Fibroblast-Conditioned Media on Human Dermal Fibroblasts Treated With Electromagnetic Transduction Therapy.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Magnetic Nanoparticles Combined With Pulsed Electromagnetic Field Alleviate Chondrocyte Necroptosis in Osteoarthritis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  12. Review
  13. The function of GPCRs in different bone cells.International journal of biological sciences · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Fabrizio VincenziDepartment of Medical Sciences, Pharmacology Unit, University of Ferrara, Ferrara, Italy.
Martina Targa
Carmen Corciulo
Stefania Gessi
Stefania Merighi
Stefania Setti
Ruggero Cadossi
Mary B Goldring
Pier Andrea Borea
Katia Varani
University of Ferrara · ITIGEA Clinical Biophysics (Italy) · ITCornell University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenosine receptors (ARs) have an important role in the regulation of inflammation and their activation is involved in the inhibition of pro-inflammatory cytokine release. The effects of pulsed electromagnetic fields (PEMFs) on inflammation have been reported and we have demonstrated that PEMFs increased A2A and A3AR density and functionality in different cell lines. Chondrocytes and osteoblasts are two key cell types in the skeletal system that play important role in cartilage and bone metabolism representing an interesting target to study the effect of PEMFs. The primary aim of the present study was to evaluate if PEMF exposure potentiated the anti-inflammatory effect of A2A and/or A3ARs in T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts. Immunofluorescence, mRNA analysis and saturation binding assays revealed that PEMF exposure up-regulated A2A and A3AR expression. A2A and A3ARs were able to modulate cAMP production and cell proliferation. The activation of A2A and A3ARs resulted in the decrease of some of the most relevant pro-inflammatory cytokine release such as interleukin (IL)-6 and IL-8, following the treatment with IL-1β as an inflammatory stimuli. In human chondrocyte and osteoblast cell lines, the inhibitory effect of A2A and A3AR stimulation on the release of prostaglandin E2 (PGE2), an important lipid inflammatory mediator, was observed. In addition, in T/C-28a2 cells, the activation of A2A or A3ARs elicited an inhibition of vascular endothelial growth factor (VEGF) secretion. In hFOB 1.19 osteoblasts, PEMF exposure determined an increase of osteoprotegerin (OPG) production. The effect of the A2A or A3AR agonists in the examined cells was enhanced in the presence of PEMFs and completely blocked by using well-known selective antagonists. These results demonstrated that PEMF exposure significantly increase the anti-inflammatory effect of A2A or A3ARs suggesting their potential therapeutic use in the therapy of inflammatory bone and joint disorders.

Indexed as

Electromagnetic FieldsAdenosine A2 Receptor AgonistsAdenosine A3 Receptor AgonistsCell LineCell ProliferationChondrocytesCyclic AMPEnzyme ActivationGene ExpressionHumansInflammationNF-kappa BOsteoblastsProtein BindingReceptor, Adenosine A2AReceptor, Adenosine A3Adenosine A2 Receptor AgonistsAdenosine A3 Receptor AgonistsCyclic AMPNF-kappa BReceptor, Adenosine A2AReceptor, Adenosine A3Receptors, Purinergic P1RNA, Messenger

Identifiers

PMID23741498
PMCPMC3669296
OpenAlexW2150792377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.